Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 15 to 19, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 15 to 19, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Approves Both Pfizer, Moderna Boosters for All Adults
FRIDAY, Nov. 19, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday granted emergency use of both the Pfizer and Moderna COVID-19 booster shots for all adults, clearing the way to additional vaccine protection for tens of millions of Americans.
New Review Claims First COVID-19 Patient Was Wuhan Market Vendor
FRIDAY, Nov. 19, 2021 (HealthDay News) — The first known person with COVID-19 was a vendor in a large seafood market in Wuhan, China, claims an American scientist whose findings challenge the World Health Organization conclusion that the first patient was an accountant who lived miles from the market.
ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths
FRIDAY, Nov. 19, 2021 (HealthDay News) — Stress to the health care system, as measured by intensive care unit bed occupancy, is associated with increases in excess deaths two, four, and six weeks later, according to research published in the Nov. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Access to Care Disrupted for Young Adults With Diabetes in COVID-19
FRIDAY, Nov. 19, 2021 (HealthDay News) — Young adults with diabetes are most likely to report having missed medical care during the COVID-19 pandemic and have lower intention of receiving COVID-19 vaccination, according to research published in the Nov. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Concerns Raised About COVID-19 Chronic Olfactory Dysfunction
FRIDAY, Nov. 19, 2021 (HealthDay News) — Chronic olfactory dysfunction as a symptom of long-term COVID-19 is emerging as a growing public health concern among U.S. individuals, according to a research letter published online Nov. 18 in JAMA Otolaryngology-Head & Neck Surgery.
Patients Hospitalized With COVID-19 Less Likely to Be Vaccinated
FRIDAY, Nov. 19, 2021 (HealthDay News) — Patients with COVID-19 hospitalization and disease progression to death or mechanical ventilation are significantly less likely to be vaccinated with an mRNA COVID-19 vaccine, according to a study published online Nov. 4 in the Journal of the American Medical Association.
Nearly 10 Percent of Younger Children Have Gotten First COVID-19 Vaccine Dose
THURSDAY, Nov. 18, 2021 (HealthDay News) — Almost one in 10 eligible U.S. children ages 5 to 11 years have received a first shot of the Pfizer COVID-19 vaccine since it was approved for that age group two weeks ago, the White House said Wednesday.
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
.jpeg)
